Federal Register / Vol. 73, No. 159 / Friday, August 15, 2008 / Notices 47957 

Officer. E-mail address: 

infocollection@acf.hhs.gov. All requests 

should be identified by the title of the 

information collection. 

The Department specifically requests 

comments on: (a) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

the quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Consideration will be given to 

comments and suggestions submitted 

within 60 days of this publication. 

Dated: August 7, 2008. 

Janean Chambers, 

Reports Clearance Officer. 

[FR Doc. E8–18790 Filed 8–14–08; 8:45 am] 

BILLING CODE 4184–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2008–N–0038] 

Bisphenol A Subcommittee of the 

Science Board to the Food and Drug 

Administration; Notice of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces the following 

meeting: Bisphenol A (BPA) 

Subcommittee of the Science Board to 

the Food and Drug Administration 

(FDA) meeting. The topic to be 

discussed is the draft assessment of BPA 

for use in food contact applications. The 

Subcommittee will hear and discuss the 

draft assessment of BPA for use in food 

contact applications, including oral 

presentations from the public. 

Date and Time: The meeting will be 

held on September 16, 2008, at 9 a.m. 

to 3:30 p.m. 

Location: Hilton Washington, 

WashingtonDC/Rockville Executive 

Meeting Center, Plaza Ballroom, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Carlos Pen ̃ a, Office of 

Science and Health Coordination, Office 

of the Commissioner (HF–33), Food and 

Drug Administration, 5600 Fishers 

Lane, (for express delivery, rm. 14B–08) 

Rockville, MD 20857, 301–827–3340, or 

by e-mail: Carlos.Pen ̃ a@fda.hhs.gov or 

FDA Advisory Committee Information 

Line, 1–800–741–8138 (301–443–0572 

in the Washington, DC area), code 

3014512603. Please call the Information 

Line for up-to-date information on this 

meeting. A notice in the Federal 

Register about last minute modifications 

that impact a previously announced 

advisory committee meeting cannot 

always be published quickly enough to 

provide timely notice. Therefore, you 

should always check the agency’s Web 

site and call the appropriate advisory 

committee hot line/phone line to learn 

about possible modifications before 

coming to the meeting. 

Agenda: The Subcommittee will hear 

and discuss the draft assessment of BPA 

for use in food contact applications, 

including oral presentations from the 

public. FDA’s draft assessment of BPA 

and FDA’s charge to the Subcommittee 

will be posted on or after August 15, 

2008, on FDA’s Web site at http:// 

www.fda.gov/ohrms/dockets/ac/ 

acmenu.htm, click on the year 2008 and 

scroll down to the appropriate advisory 

committee link. 

FDA intends to make background 

material available to the public no later 

than 2 business days before the meeting. 

If FDA is unable to post the background 

material on its Web site prior to the 

meeting, the background material will 

be made publicly available at the 

location of the advisory committee 

meeting, and the background material 

will be posted on FDA’s Web site after 

the meeting. Background material is 

available at http://www.fda.gov/ohrms/ 

dockets/ac/acmenu.htm, click on the 

year 2008 and scroll down to the 

appropriate advisory committee link. 

Procedure: Interested persons may 

present data, information, or views, 

orally or in writing, on issues pending 

before the Subcommittee. Written 

submissions may be made to the contact 

person on or before September 12, 2008. 

Oral presentations from the public will 

be scheduled between approximately 11 

a.m. and 12 noon and between 

approximately 1 p.m. and 2 p.m. on 

September 16, 2008. Those desiring to 

make formal oral presentations should 

notify the contact person and submit a 

brief statement of the general nature of 

the evidence or arguments they wish to 

present, the names and addresses of 

proposed participants, and an 

indication of the approximate time 

requested to make their presentation on 

or before September 4, 2008. Time 

allotted for each presentation may be 

limited. If the number of registrants 

requesting to speak is greater than can 

be reasonably accommodated during the 

scheduled open public hearing session, 

FDA may conduct a lottery to determine 

the speakers for the scheduled open 

public hearing session. The contact 

person will notify interested persons 

regarding their request to speak by 

September 5, 2008. 

Persons attending FDA’s advisory 

committee meetings are advised that the 

agency is not responsible for providing 

access to electrical outlets. 

FDA welcomes the attendance of the 

public at its advisory committee 

meetings and will make every effort to 

accommodate persons with physical 

disabilities or special needs. If you 

require special accommodations due to 

a disability, please contact Dr. Carlos 

Pen ̃ a at least 7 days in advance of the 

meeting. 

FDA is committed to the orderly 

conduct of its advisory committee 

meetings. Please visit our Web site at 

http://www.fda.gov/oc/advisory/ 

default.htm for procedures on public 

conduct during advisory committee 

meetings. 

Notice of this meeting is given under 

the Federal Advisory Committee Act (5 

U.S.C. app. 2). 

Dated: August 11, 2008. 

Jeffrey Shuren, 

Associate Commissioner for Policy and 

Planning. 

[FR Doc. E8–18864 Filed 8–14–08; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Services Subcommittee of the 

Interagency Autism Coordinating 

Committee (IACC). 

The purpose of the Services 

Subcommittee is to review the current 

state of services and supports for 

individuals with Autism Spectrum 

Disorder (ASD) and their families in 

order to improve these services. The 

Subcommittee meeting will be 

conducted as a telephone conference 

call with presentations on the Web. This 

meeting is open for the public to call in 

to listen and to access the Web 

presentations. The Subcommittee will 

report on its meeting at the next meeting 

of the IACC on November 21, 2008. 

Name of Committee: Interagency Autism 

Coordinating Committee (IACC). 

mstockstill on PROD1PC66 with NOTICES